{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:46:33Z","timestamp":1780490793479,"version":"3.54.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To evaluate the effects of prophylactic piperacillin-tazobactam (PT) on inpatient acute kidney injury (AKI) and fracture-related infection (FRI) in patients with open fractures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>The study was conducted at a Level 1 trauma center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>We reviewed 358 Gustilo\u2013Anderson type II and III open fractures at our institution from January 2013 to December 2017.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Administration of PT (the PT group) or antibiotics other than PT (the historical control group) during the first 48 hours of arrival for open fracture antibiotic prophylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Outcome Measurements:<\/jats:title>\n            <jats:p>The main outcome measurements were rates of inpatient AKI and FRI within six months after definitive fixation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>There were 176 patients in the PT group and 182 patients in the historical control group. The PT group had worse American Society of Anesthesiologists class (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004) and injury severity scores (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), a higher average number of debridements before closure\/coverage (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.043), and higher rates of gross soil contamination (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.049) and staged procedures (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.008) compared with the historical control group.<\/jats:p>\n            <jats:p>There was no difference in the rate of AKI between the PT and historical control groups (5.7% vs. 2.7%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.166) nor when stratified by Gustilo\u2013Anderson fracture classification (type II: 5.8% vs. 3.6%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.702; type III: 5.6% vs. 2.0%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.283). There was no significant difference in the rate of FRI between the PT and historical control groups (23.6% vs. 19.6%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.469).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The use of PT in prophylactic antimicrobial treatment in patients with Gustilo\u2013Anderson type II and III open fractures does not increase the rate of AKI or FRI. We believe PT can be used as an effective monotherapy in these patients without an increased risk of renal injury, but future investigations are necessary.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level of Evidence:<\/jats:title>\n            <jats:p>Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bot.0000000000002473","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T23:00:08Z","timestamp":1661382008000},"page":"e73-e79","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Risk of Acute Kidney Injury and Fracture-Related Infection After Antibiotic Prophylaxis With Piperacillin-Tazobactam in Open Fractures"],"prefix":"10.1097","volume":"37","author":[{"given":"Thompson","family":"McMurtrie","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Cone","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Mihas","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Patch","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clay A.","family":"Spitler","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, AL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0020-1383(98)00125-9","article-title":"The epidemiology of open long bone fractures","volume":"29","author":"Court-Brown","year":"1998","journal-title":"Injury"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2106\/00004623-200704000-00027","article-title":"Management of open fractures and subsequent complications","volume":"89","author":"Zalavras","year":"2007","journal-title":"J Bone Jt Surg Am"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00402-018-3048-0","article-title":"Insights into treatment and outcome of fracture-related infection: a systematic literature review","volume":"139","author":"Bezstarosti","year":"2019","journal-title":"Arch Orthop Trauma Surg"},{"key":"R4-20250614","doi-asserted-by":"crossref","DOI":"10.1016\/j.injury.2021.08.023","article-title":"Fracture-related infection in long bone fractures: a comprehensive analysis of the economic impact and influence on quality of life","author":"Iliaens","year":"2021","journal-title":"Injury"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.injury.2016.09.019","article-title":"Infection after fracture fixation: current surgical and microbiological concepts","volume":"49","author":"Metsemakers","year":"2018","journal-title":"Injury"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1302\/0301-620X.100B11.BJJ-2018-0308.R1","article-title":"Economic outcomes associated with deep surgical site infection in patients with an open fracture of the lower limb","volume":"100-B","author":"Parker","year":"2018","journal-title":"Bone Joint J"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1302\/0301-620X.100B4.BJJ-2017-0891.R1","article-title":"A qualitative study of patient experience of an open fracture of the lower limb during acute care","volume":"100-B","author":"Tutton","year":"2018","journal-title":"Bone Jt J"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1308\/003588415X14181254788845","article-title":"Cost of infection after surgery for intracapsular fracture of the femoral neck","volume":"97","author":"Wijeratna","year":"2015","journal-title":"Ann R Coll Surg Engl"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5435\/JAAOS-D-16-00127","article-title":"Management of open tibial shaft fractures: does the timing of surgery affect outcomes?","volume":"25","author":"Duyos","year":"2017","journal-title":"J Am Acad Orthop Surg"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOT.0000000000000262","article-title":"Type III open tibia fractures: immediate antibiotic prophylaxis minimizes infection","volume":"29","author":"Lack","year":"2015","journal-title":"J Orthop Trauma"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.2106\/JBJS.19.01070","article-title":"Musculoskeletal infection in orthopaedic trauma: assessment of the 2018 international consensus meeting on musculoskeletal infection","volume":"102","author":"Obremskey","year":"2020","journal-title":"J Bone Jt Surg Am"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00003086-198906000-00006","article-title":"Factors influencing infection rate in open fracture wounds","volume":"243","author":"Patzakis","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2106\/00004623-197658040-00004","article-title":"Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses","volume":"58","author":"Gustilo","year":"1976","journal-title":"J Bone Jt Surg Am"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2106\/JBJS.RVW.17.00197","article-title":"Antibiotic prophylaxis in the management of open fractures: a systematic survey of current practice and recommendations","volume":"7","author":"Chang","year":"2019","journal-title":"JBJS Rev"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/BOT.0000000000001282","article-title":"Risk factors for kidney dysfunction with the use of gentamicin in open fracture antibiotic treatment","volume":"32","author":"Folse","year":"2018","journal-title":"J Orthop Trauma"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5435\/JAAOS-D-18-00193","article-title":"Antibiotic prophylaxis in open fractures: evidence, evolving issues, and recommendations","volume":"28","author":"Garner","year":"2020","journal-title":"J Am Acad Orthop Surg"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2106\/00004623-200204000-00029","article-title":"Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses","volume":"84","author":"Gustilo","year":"2002","journal-title":"The J Bone Jt Surgery-American"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/SLA.0b013e3181a40a0b","article-title":"Long-term risk of mortality and acute kidney injury during hospitalization after major surgery","volume":"249","author":"Bihorac","year":"2009","journal-title":"Ann Surg"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"JASN"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.38.4.905","article-title":"Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues","volume":"38","author":"Incavo","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11739-020-02287-2","article-title":"Acute kidney injury and vancomycin\/piperacillin\/tazobactam in adult patients: a systematic review","volume":"15","author":"Ciarambino","year":"2020","journal-title":"Intern Emerg Med"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40780-019-0142-6","article-title":"Higher incidence of acute kidney injury in patients treated with piperacillin\/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study","volume":"5","author":"Kadomura","year":"2019","journal-title":"J Pharm Health Care Sci"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","article-title":"Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systematic review and meta-analysis","volume":"46","author":"Luther","year":"2018","journal-title":"Crit Care Med"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/cid\/ciw709","article-title":"Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin\u2013tazobactam compared to those on vancomycin and cefepime","volume":"64","author":"Navalkele","year":"2017","journal-title":"CLINID"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/BOT.0000000000000554","article-title":"Surgical site infections in patients with type 3 open fractures: comparing antibiotic prophylaxis with cefazolin plus gentamicin versus piperacillin\/tazobactam","volume":"30","author":"Redfern","year":"2016","journal-title":"J Orthop Trauma"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TA.0000000000000398","article-title":"Evidence-based protocol for prophylactic antibiotics in open fractures: improved antibiotic stewardship with no increase in infection rates","volume":"77","author":"Rodriguez","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"77","DOI":"10.12788\/jhm.2684","article-title":"Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: a retrospective cohort analysis","volume":"12","author":"Rutter","year":"2017","journal-title":"J Hosp Med"},{"issue":"1","key":"R28-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/sur.2019.064","article-title":"Piperacillin\/tazobactam versus tobramycin-based antibiotic prophylaxis for type III open fractures","volume":"21","author":"Shawar","year":"2020","journal-title":"Surg Infect"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfm744","article-title":"A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients","volume":"23","author":"Bagshaw","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/cc4915","article-title":"RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis","volume":"10","author":"Hoste","year":"2006","journal-title":"Crit Care"},{"key":"R32-20250614","first-page":"751","article-title":"East Practice Management Guidelines Work Group: update to practice management guidelines for prophylactic antibiotic use in open fractures","volume":"70","author":"Hoff","year":"2011","journal-title":"J Trauma"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00068-017-0847-x","article-title":"Antibiotics and open fractures of the lower extremity: less is more","volume":"45","author":"Bankhead-Kendall","year":"2019","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.injury.2016.01.018","article-title":"Antibiotic related acute kidney injury in patients treated for open fractures","volume":"47","author":"Pannell","year":"2016","journal-title":"Injury"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1097\/MJT.0000000000001121","article-title":"Cefazolin monotherapy versus cefazolin plus aminoglycosides for antimicrobial prophylaxis of type III open fractures","volume":"28","author":"Patanwala","year":"2021","journal-title":"Am J Ther"},{"key":"R36-20250614","first-page":"239","article-title":"Comparison the efficacy of cefazolin plus gentamicin with cefazolin plus Ciprofloxacin in management of type-IIIA open fractures","volume":"13","author":"Janmohammadi","year":"2011","journal-title":"Iran Red Crescent Med J"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2106\/JBJS.20.01229","article-title":"Low adherence to recommended guidelines for open fracture antibiotic prophylaxis","volume":"103","author":"Lin","year":"2021","journal-title":"J Bone Jt Surg"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005131-200011000-00002","article-title":"Prospective, randomized, double-blind study comparing single-agent antibiotic therapy, ciprofloxacin, to combination antibiotic therapy in open fracture wounds","volume":"14","author":"Patzakis","year":"2000","journal-title":"J Orthop Trauma"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/phar.1851","article-title":"Is the combination of piperacillin-tazobactam and vancomycin associated with development of acute kidney injury? A meta-analysis","volume":"36","author":"Giuliano","year":"2016","journal-title":"Pharmacotherapy"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1302\/0301-620X.100B2.BJJ-2017-0367.R1","article-title":"An interobserver reliability comparison between the Orthopaedic Trauma Association's open fracture classification and the Gustilo and Anderson classification","volume":"100-B","author":"Ghoshal","year":"2018","journal-title":"Bone Joint J."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:04:49Z","timestamp":1749924289000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002473","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-08-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}